D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
EWTX holding history
Edgewise Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EWTX overviewAll 13F holders of EWTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 189,115
- Value
- $7.68M
- % of portfolio
- <0.1%
- Quarters held
- 15
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 189,115 | $7.68M | <0.1% | +84,252+80.3% | Added | Holders |
| Q1 2026 | 104,863 | $3.30M | <0.1% | −289,832−73.4% | Reduced | Holders |
| Q4 2025 | 394,695 | $9.79M | <0.1% | −282,866−41.7% | Reduced | Holders |
| Q3 2025 | 677,561 | $11.0M | <0.1% | +82,129+13.8% | Added | Holders |
| Q2 2025 | 595,432 | $7.81M | <0.1% | +454,884+323.7% | Added | Holders |
| Q1 2025 | 140,548 | $3.09M | <0.1% | −545,823−79.5% | Reduced | Holders |
| Q4 2024 | 686,371 | $18.3M | <0.1% | +231,023+50.7% | Added | Holders |
| Q3 2024 | 455,348 | $12.2M | <0.1% | +143,872+46.2% | Added | Holders |
| Q2 2024 | 311,476 | $5.61M | <0.1% | −162,204−34.2% | Reduced | Holders |
| Q1 2024 | 473,680 | $8.64M | <0.1% | +441,730+1,382.6% | Added | Holders |
| Q4 2023 | 31,950 | $349.5K | <0.1% | +31,950 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −24,736−100.0% | Sold out | Holders |
| Q1 2023 | 24,736 | $165.0K | <0.1% | +13,462+119.4% | Added | Holders |
| Q4 2022 | 11,274 | $100.8K | <0.1% | +11,274 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −13,695−100.0% | Sold out | Holders |
| Q3 2021 | 13,695 | $227.0K | <0.1% | −32,472−70.3% | Reduced | Holders |
| Q2 2021 | 46,167 | $985.0K | <0.1% | +46,167 | New | Holders |